Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
ખોલો
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.21%
1,091.51
-2.30
-0.21%
1,093.811,096.521,100.221,091.51
SIXC
Communications
SIXC
Communications
SIXC
+0.22%
610.11
+1.34
+0.22%
608.77608.77612.97608.77
SIXE
Energy
SIXE
Energy
SIXE
-1.34%
1,237.98
-16.83
-1.34%
1,254.811,253.011,253.871,226.33
SIXI
Industrials
SIXI
Industrials
SIXI
-0.93%
1,744.71
-16.40
-0.93%
1,761.111,764.271,766.881,744.71
SIXM
Financials
SIXM
Financials
SIXM
-0.37%
640.18
-2.40
-0.37%
642.58644.87648.48640.18
SIXR
Staples
SIXR
Staples
SIXR
-0.18%
849.58
-1.55
-0.18%
851.13855.66858.75845.56
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.23%
217.48
-0.50
-0.23%
217.98217.98218.65216.88
SIXT
Technology
SIXT
Technology
SIXT
+1.52%
3,260.69
+48.86
+1.52%
3,211.833,227.213,268.383,226.55
SIXU
Utilities
SIXU
Utilities
SIXU
-0.69%
942.45
-6.53
-0.69%
948.98948.58957.83941.97
SIXV
Health care
SIXV
Health care
SIXV
-0.52%
1,466.80
-7.72
-0.52%
1,474.521,479.031,481.041,466.80
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.22%
2,397.50
+5.38
+0.22%
2,392.122,396.952,421.222,382.32
4507:TYO
Shionogi & Co Ltd
JP¥3,128.00
-1.32%
(-42.00) 1D
1 મે, 03:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4507...
ખોલો
JP¥3,172
High
JP¥3,174
Low
JP¥3,112
Mkt. cap
૨.૭૮ મહાપદ્મ
Avg. vol.
૨૮.૧૯ લાખ
Volume
૨૩.૨૮ લાખ
Dividend
૨.૧૧%
Quarterly dividend
JP¥16
Ex dividend date
29 સપ્ટે, 2025
P/E ratio
૧૩.૬૬
52-wk high
JP¥3,758
52-wk low
JP¥2,162
EPS
JP¥229
Shares outstanding
૩૧.૪૫ કરોડ
No. of employees
૫ હજાર
News stories
From sources across the web
Simply Wall Street
Simply Wall Street
·
2 કલાક પહેલાં
Is It Too Late To Consider Ichor Holdings (ICHR) After A 216% Yearly Surge?
Seymour Tribune
Seymour Tribune
·
7 કલાક પહેલાં
Column: Buffett — Predicting doesn’t count; building arks does
પ્રોફાઇલ
Shionogi & Company, Limited is a Japanese pharmaceutical company best known for developing Crestor. Medical supply and brand name also uses katakana. Shionogi has business roots that date back to 1878, and was incorporated in 1919. Among the medicines produced are for hyperlipidaemia, antibiotics, and cancer medicines. In Japan it is particularly known as a producer of antimicrobial and antibiotics. Because of antibiotic resistance and slow growth of the antibiotic market, it has teamed up with US based Schering-Plough to become a sole marketing agent for its products in Japan. Shionogi had supported the initial formation of Ranbaxy Pharmaceuticals, a generic manufacturer based in India. In 2012 the company became a partial owner of ViiV Healthcare, a pharmaceutical company specialising in the development of therapies for HIV. The company is listed on the Tokyo Stock Exchange and Osaka Securities Exchange and is constituent of the Nikkei 225 stock index. In June 2023, Shionogi announced its acquisition of Qpex Biopharma for approximately $140m. Wikipedia
About Shionogi & Co Ltd
CEOઈસાઓ તેશિરોગી
Employees4.96 હજાર
Founded1878
HeadquartersOsaka, Osaka, જાપાન
Sector-
Last report
30 જાન્યુ, 2026
Fiscal Period
Q3 2026
Normalized EPS / Estimate
-/ -JPY
Revenue / Estimate
૧.૪૮ નિખર્વ/ (૧.૩૮ નિખર્વ est.)JPY
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
માર્ચ 2025
જૂન 2025
સપ્ટે 2025
ડિસે 2025
Revenue
1.05 નિખર્વ
99.78 અબજ
1.13 નિખર્વ
1.48 નિખર્વ
Cost of goods sold
17.79 અબજ
12.32 અબજ
16.94 અબજ
25.09 અબજ
Cost of revenue
17.79 અબજ
12.32 અબજ
16.94 અબજ
25.09 અબજ
Research and development expenses
29.16 અબજ
24.89 અબજ
27.55 અબજ
29.87 અબજ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
23.87 અબજ
25.82 અબજ
27.56 અબજ
35.27 અબજ
Operating expense
56.78 અબજ
52.37 અબજ
56.57 અબજ
48.45 અબજ
Total operating expenses
74.57 અબજ
64.68 અબજ
73.51 અબજ
73.54 અબજ
Operating income
30.10 અબજ
35.10 અબજ
39.67 અબજ
74.18 અબજ
Other non operating income
-1.14 અબજ
-10.00 લાખ
-
-10.00 લાખ
EBT including unusual items
44.87 અબજ
46.33 અબજ
52.06 અબજ
92.89 અબજ
EBT excluding unusual items
53.35 અબજ
46.33 અબજ
52.06 અબજ
93.10 અબજ
Income tax expense
8.68 અબજ
6.98 અબજ
7.87 અબજ
18.21 અબજ
Effective tax rate
19.33%
15.07%
15.12%
19.60%
Other operating expenses
-2.00 અબજ
1.17 અબજ
97.90 કરોડ
-17.25 અબજ
Net income
36.63 અબજ
39.36 અબજ
44.19 અબજ
74.68 અબજ
Net profit margin
35.00%
39.44%
39.04%
50.56%
Earnings per share
-
-
-
-
Interest and investment income
25.40 અબજ
13.56 અબજ
14.21 અબજ
20.53 અબજ
Interest expense
-
-2.33 અબજ
-1.82 અબજ
-1.61 અબજ
Net interest expenses
25.40 અબજ
11.23 અબજ
12.38 અબજ
18.92 અબજ
Depreciation and amortization charges
-3.26 અબજ
-
-48.50 કરોડ
-
EBITDA
35.30 અબજ
40.11 અબજ
44.83 અબજ
80.21 અબજ
Gain or loss from assets sale
25.40 કરોડ
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more